Fetal Monitors in Georgia

Femasys Inc. is a woman-founded and led biomedical company dedicated to enhancing women's healthcare through innovative, minimally invasive, non-surgical technologies. The company focuses on addressing significant needs in infertility, contraception, and cancer diagnostics. With a mission to provide safe and accessible solutions, Femasys aims to improve patient care and health standards globally, supported by a robust portfolio of approximately 200 patents. The company develops a range of therapeutic and diagnostic products using a proprietary non-surgical delivery platform. Key offerings include FemaSeed, an intratubal insemination device; FemVue, an ultrasound-based diagnostic tool; FemBloc, a candidate for non-surgical birth control; and FemCerv, a tissue sampler for cervical cancer diagnosis. Femasys emphasizes safety and efficiency in its in-office approaches, with a commitment to empowering women throughout their reproductive journeys. The company is publicly traded on NASDAQ under the ticker FEMY.

Clinical Guard is a B2B/B2C homecare and personal medical device supplier operating since 2006. The company distributes a range of portable home health monitoring and diagnostic products under the Clinical Guard brand and other manufacturers. Core product lines include pulse oximetry systems (fingertip and wearable variants), ultrasonic nebulizers for respiratory therapy, ovulation and pregnancy test strips, and fetal heart rate monitoring devices (Doppler-based). The product portfolio is designed for consumer self-monitoring, fertility tracking, and prenatal home assessment. Clinical Guard operates an e-commerce platform offering free shipping on orders, positioning itself as a retail and potentially wholesale supplier to individuals and small healthcare facilities seeking affordable, accessible home diagnostic equipment.

CorDx Labs is a biotechnology company specializing in in vitro diagnostic (IVD) products for point-of-care and over-the-counter use. With 18+ years of industry experience, CorDx operates a vertically integrated supply chain with manufacturing facilities across the United States and internationally, serving 170+ countries through a global network of 700+ partners. The company manufactures and distributes a portfolio of 1,000+ diagnostic products spanning infectious disease testing (including multiplex rapid tests for flu, COVID-19, and RSV), reproductive and fertility testing, molecular diagnostics, and pet diagnostics. CorDx also offers contract manufacturing services for diagnostic products across multiple therapeutic areas, leveraging advanced quality and compliance systems to ensure operational excellence.